Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesEvidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines
Current Medical Research and Opinion, 08/20/09
Simoens S – CAP guidelines need to take into account pharmaco–economic considerations by balancing the effectiveness of antimicrobial regimens against their costs. The pharmaco–economic value of moxifloxacin is influenced by the causative pathogens involved and resistance patterns. Therefore, it may be advisable to identify patient subgroups in which treatment with moxifloxacin is cost–effective and should be recommended by guidelines.
Related Articles
Influenza is a Major Contributor to Childhood Pneumonia in a Tropical Developing Country
The Pediatric Infectious Disease Journal, 10/05/09
Relevance Score: 93%
Streptococcus pneumoniae-associated haemolytic uremic syndrome following influenza A virus infection
European Journal of Pediatrics, 11/17/09
Relevance Score: 92%
Discordant Chest Radiographs - A Pitfall in Febrile Elderly Patients With Pneumonia
International Journal of Gerontology, 10/09/09
Relevance Score: 92%
Monomicrobial necrotizing fasciitis in a white male caused by hypermucoviscous Klebsiella pneumoniae
Journal of Medical Microbiology, 10/21/09
Relevance Score: 91%
Role of atypical pathogens among adult hospitalized patients with community-acquired pneumonia
Respirology, 10/09/09
Relevance Score: 90%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oral Immunotherapy with inactivated NTHi reduces severity of acute exacerbations in severe COPD
Chest, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 12/16/09
Today in Pulm/Thoracic Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
A comparison of culture-positive and culture-negative healthcare-associated pneumonia
Chest, 12/16/09
Ecological Effects of Selective Decontamination on Resistant Gram-negative Bacterial Colonization
American Journal of Respiratory and Critical Care Medicine, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor